Hu P - Search Results

1

Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis.

Hu P, Yan J, Sharifi J, Bai T, Khawli LA, Epstein AL. Hu P, et al. Cancer Res. 2003 Aug 15;63(16):5046-53. Cancer Res. 2003. PMID: 12941833

2

Stable, genetically engineered F(ab')(2) fragments of chimeric TNT-3 expressed in mammalian cells.

Khawli LA, Biela BH, Hu P, Epstein AL. Khawli LA, et al. Among authors: hu p. Hybrid Hybridomics. 2002 Feb;21(1):11-8. doi: 10.1089/15368590252917593. Hybrid Hybridomics. 2002. PMID: 11991812

3

Pharmacokinetic characteristics and biodistribution of radioiodinated chimeric TNT-1, -2, and -3 monoclonal antibodies after chemical modification with biotin.

Khawli LA, Mizokami MM, Sharifi J, Hu P, Epstein AL. Khawli LA, et al. Among authors: hu p. Cancer Biother Radiopharm. 2002 Aug;17(4):359-70. doi: 10.1089/108497802760363150. Cancer Biother Radiopharm. 2002. PMID: 12396700

4

Generation of human interferon gamma and tumor Necrosis factor alpha chimeric TNT-3 fusion proteins.

Sharifi J, Khawli LA, Hu P, Li J, Epstein AL. Sharifi J, et al. Among authors: hu p. Hybrid Hybridomics. 2002 Dec;21(6):421-32. doi: 10.1089/153685902321043954. Hybrid Hybridomics. 2002. PMID: 12573106

5

Generation of low-toxicity interleukin-2 fusion proteins devoid of vasopermeability activity.

Hu P, Mizokami M, Ruoff G, Khawli LA, Epstein AL. Hu P, et al. Blood. 2003 Jun 15;101(12):4853-61. doi: 10.1182/blood-2002-10-3089. Epub 2003 Feb 27. Blood. 2003. PMID: 12609842 Free article.

6

Comparison of recombinant derivatives of chimeric TNT-3 antibody for the radioimaging of solid tumors.

Khawli LA, Biela B, Hu P, Epstein AL. Khawli LA, et al. Among authors: hu p. Hybrid Hybridomics. 2003 Feb;22(1):1-9. doi: 10.1089/153685903321538026. Hybrid Hybridomics. 2003. PMID: 12713684

7

LEC/chTNT-3 fusion protein for the immunotherapy of experimental solid tumors.

Li J, Hu P, Khawli LA, Epstein AL. Li J, et al. Among authors: hu p. J Immunother. 2003 Jul-Aug;26(4):320-31. doi: 10.1097/00002371-200307000-00004. J Immunother. 2003. PMID: 12843794

8

Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).

Biela BH, Khawli LA, Hu P, Epstein AL. Biela BH, et al. Among authors: hu p. Cancer Biother Radiopharm. 2003 Jun;18(3):339-53. doi: 10.1089/108497803322285099. Cancer Biother Radiopharm. 2003. PMID: 12954121

9

Chimeric TNT-3 antibody/murine interferon-gamma fusion protein for the immunotherapy of solid malignancies.

Mizokami MM, Hu P, Khawli LA, Li J, Epstein AL. Mizokami MM, et al. Among authors: hu p. Hybrid Hybridomics. 2003 Aug;22(4):197-207. doi: 10.1089/153685903322328929. Hybrid Hybridomics. 2003. PMID: 14511565

10

Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.

Li J, Hu P, Khawli LA, Epstein AL. Li J, et al. Among authors: hu p. Cancer Res. 2003 Dec 1;63(23):8384-92. Cancer Res. 2003. PMID: 14679000

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,936 results

Search Page

Filters